Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

29.97 -1.39 (-4.43%)
Streaming Delayed Price Updated: 2:47 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEAYA Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
US Stocks Edge Higher; Coca-Cola Posts Upbeat Results
U.S. stocks traded slightly higher this morning, with the Dow Jones gaining around 30 points on Monday. Following the market opening Monday, the Dow traded up 0.10% to 33,843.10 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Via Benzinga
Philips, Credit Suisse And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023
 
Via Benzinga
IDEAYA Biosciences's Return On Capital Employed Insights
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 28, 2022
 
Via Benzinga
Where IDEAYA Biosciences Stands With Analysts
Analysts have provided the following ratings for IDEAYA Biosciences (NASDAQ:IDYA) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023
 
Via Benzinga
Buy/Sell: Wall Street's Top 5 Stock Calls This Week - Sunday, Jan. 1
What was Wall Street buzzing about this past week? Let's take a closer look at the top 5 buy calls made by Wall Street’s best analysts during the week of Dec. 26-30, 2022. 
Via Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
Upgrades 
Via Benzinga
IDEAYA Shares Jump On Positive Interim Data From Eye Cancer Trial
 
Via Benzinga
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome... 
Via Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Good morning! It's time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning! 
Via InvestorPlace
Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
U.S. stock futures traded higher this morning ahead of several economic reports. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Why Ideaya Biosciences Shares Are Falling Sharply During Wednesday's After-Hours Session
Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 10.07% to $11.25 during Wednesday's after-hours session. The company announced an $80 million common stock offering. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million. 
Via Benzinga
Where IDEAYA Biosciences Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on IDEAYA Biosciences (NASDAQ:IDYA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding... 
Via Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. 
Via Benzinga
US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises
Pre-open movers 
Via Benzinga
Oracle, JPMorgan And 3 Stocks To Watch Heading Into Monday
With US stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Looking Into IDEAYA Biosciences's Return On Capital Employed
Benzinga Pro data, IDEAYA Biosciences (NASDAQ:IDYA) reported Q2 sales of $5.85 million. Earnings fell to a loss of $22.06 million, resulting in a 57.4% decrease from last quarter. 
Via Benzinga
IDEAYA Shares Climb As Initial Stage Uveal Melanoma Study Kick-off In Australia
IDEAYA Biosciences (NASDAQ: IDYA) has initiated Investigator Sponsored Trial to evaluate darovasertib as monotherapy in neo-adjuvant and adjuvant settings in primary, non-metastatic uveal melanoma (UM)... 
Via Benzinga
IDEAYA Achieves First Milestone In GSK Pact For Pol Theta Helicase Inhibitor Candidate
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
AppLovin, Unity Software And Some Other Big Losers From Monday
U.S. stocks closed higher on Monday, with the Dow Jones gaining around 150 points. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.